University of Belgrade, Faculty of Biology, Institute of Botany and Botanical Garden "Jevremovac", Studentski trg 16, 11000 Belgrade, Serbia.
University of Niš, Faculty of Medicine, Department of Pharmacy, Bulevar Dr. Zorana Đinđića 81, 18000 Niš, Serbia.
Mini Rev Med Chem. 2022;22(10):1395-1419. doi: 10.2174/1389557521666211116122232.
The beneficial effect of plants in treating diabetes is not only well-known in traditional medicine but also confirmed in numerous scientific studies. The basic platform for testing the potential antidiabetic activity of traditionally known plants and their bioactive compounds is a set of in vitro, in vivo experiments, clinical trials, and molecular docking studies. Basic assays usually measure enzyme inhibitory activity (α-amylase and α-glucosidase) and other aspects related to diabetes mellitus disease. Recently, the use of plant-derived compounds has proven useful in treating diabetes and reducing complications resulting from high blood sugar levels. The main goal is to establish an action mechanism of plant extracts or active compounds to find new antidiabetic drugs with less toxicological properties. This work aims to collect data and discuss the newest results in the area of plant extracts, compounds, and antidiabetic effects using in vitro, in vivo, and in silico models. The data covered in this review include plant extracts, polyphenols, terpenoids, saponins, phytosterols, and other bioactive compounds, with some of the investigated plants being less known. Isolation of new compounds might be a plentiful source for treatment and prevention of diabetes mellitus. Clinical trials with adequate monitoring give the best results of plants' product efficacy and safety. Many studies have confirmed the importance of patent and use of medicinal herbs in the treatment of diabetes.
植物在治疗糖尿病方面的有益作用不仅在传统医学中众所周知,而且在众多科学研究中也得到了证实。测试传统上已知的植物及其生物活性化合物的潜在抗糖尿病活性的基本平台是一系列体外、体内实验、临床试验和分子对接研究。基础测定通常测量酶抑制活性(α-淀粉酶和α-葡萄糖苷酶)和与糖尿病疾病相关的其他方面。最近,植物衍生化合物的使用已被证明可有效治疗糖尿病并减少高血糖水平引起的并发症。主要目标是建立植物提取物或活性化合物的作用机制,以寻找具有较少毒理学特性的新型抗糖尿病药物。这项工作旨在使用体外、体内和计算模型收集有关植物提取物、化合物和抗糖尿病作用的最新研究结果并进行讨论。本综述涵盖的资料包括植物提取物、多酚、萜类、皂苷、植物固醇和其他生物活性化合物,其中一些研究的植物不太为人所知。分离新化合物可能是治疗和预防糖尿病的丰富来源。有充分监测的临床试验可获得植物产品功效和安全性的最佳结果。许多研究证实了专利和草药在治疗糖尿病中的重要性。